22 May 2013
Keywords: medichem, gets, commercialization, rights, anti-hiv, calanolides, results
Article | 11 September 1995
The results of the PICO study of pimobendan in patients with chronic
congestive heart failure may spell the end to ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
18 September 1995
4 September 1995
© 2013 thepharmaletter.com